Clinic
Medical Associates of Ebnhc
Medical Associates of Ebnhc was paid $179.33M by Medicaid between Jan 2018 and Dec 2024, across 368 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoMEDICAL ASSOCIATES OF EBNHC
EAST BOSTON, MA 02128
EAST BOSTON, MA 02128
33aNPI1255451597assigned 03/30/2007
33bProvider typeCommunity Health Clinic/Center
28Total paid$179.33M
24GClaims3,014,616
24DCodes billed368
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in Massachusetts
Rank by total paid#1 of 36
Median peer was paid$3.62M
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 365,187 | $22.19M | |
| 2019 | 397,054 | $25.93M | |
| 2020 | 371,799 | $24.79M | |
| 2021 | 586,542 | $33.31M | |
| 2022 | 616,071 | $38.64M | |
| 2023 | 391,961 | $20.55M | |
| 2024incomplete | 286,002 | $13.92M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 516,080 | 438,236 | $52.93M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 232,272 | 213,074 | $23.39M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.6% | 83,212 | 79,198 | $10.06M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.5% | 107,971 | 99,514 | $9.80M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.6% | 52,626 | 50,230 | $6.39M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.5% | 43,521 | 39,151 | $4.50M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.3% | 39,776 | 39,527 | $4.08M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 36,004 | 34,319 | $3.94M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 8,562 | 8,110 | $3.89M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.1% | 20,739 | 20,072 | $3.85M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.8% | 45,258 | 44,932 | $3.27M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 31,436 | 31,249 | $3.04M |
356 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 38,891 | $2.44M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 23,853 | $2.43M |
| 99215 | Doctor's office visit, returning patient (complex) | 1.1% | 19,163 | $2.03M |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 19,463 | $1.69M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 3,335 | $1.69M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 21,634 | $1.44M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 109,553 | $1.43M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 18,278 | $1.25M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 36,307 | $1.21M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 17,943 | $1.15M |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 25,815 | $1.14M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 16,876 | $1.13M |
| 90651 | <1% | 13,445 | $1.10M | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 8,838 | $1.06M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13,212 | $925K |
| 92551 | <1% | 7,610 | $915K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 39,064 | $848K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 8,439 | $763K |
| 76830 | Ultrasound, transvaginal | <1% | 13,049 | $760K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12,597 | $734K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 9,984 | $728K |
| 90688 | <1% | 63,725 | $726K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 6,935 | $697K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 24,290 | $691K |
| 99381 | <1% | 4,610 | $571K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 1,051 | $539K |
| 0002A | <1% | 17,049 | $538K | |
| D9450 | <1% | 82,325 | $532K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 7,323 | $517K |
| 0001A | <1% | 16,995 | $503K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 4,805 | $496K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 11,877 | $489K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,296 | $468K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 55,807 | $449K |
| 11981 | <1% | 2,612 | $432K | |
| 99173 | <1% | 22,830 | $425K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 14,084 | $407K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,042 | $400K |
| D1120 | Dental cleaning, child | <1% | 7,899 | $386K |
| 20610 | <1% | 4,055 | $375K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 42,453 | $365K |
| 87430 | <1% | 29,558 | $339K | |
| 58300 | <1% | 2,466 | $328K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 15,715 | $328K |
| D0120 | Dental checkup, returning patient | <1% | 21,162 | $323K |
| 81025 | <1% | 64,009 | $281K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 10,206 | $269K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 22,668 | $266K |
| D1110 | Prophylaxis - adult | <1% | 19,230 | $249K |
| 57454 | <1% | 1,737 | $235K | |
| 90715 | <1% | 14,270 | $233K | |
| 90750 | <1% | 2,768 | $233K | |
| 0134A | <1% | 5,650 | $229K | |
| 92587 | <1% | 1,151 | $228K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 37,558 | $225K |
| 12001 | <1% | 1,090 | $225K | |
| 11982 | <1% | 2,685 | $224K | |
| S4989 | Contraceptive intrauterine device (e.g., progestacert iud), including implants and supplies | <1% | 375 | $217K |
| 76770 | <1% | 1,866 | $200K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,996 | $187K |
| D1351 | Sealant - per tooth | <1% | 5,020 | $185K |
| 92341 | <1% | 3,977 | $182K | |
| 58301 | <1% | 1,893 | $175K | |
| D1206 | Topical application of fluoride varnish | <1% | 6,985 | $172K |
| D0274 | Bitewings - four radiographic images | <1% | 9,150 | $171K |
| 59426 | <1% | 874 | $163K | |
| 90746 | <1% | 6,356 | $150K | |
| 58100 | <1% | 1,014 | $149K | |
| 0054A | <1% | 3,778 | $149K | |
| 0004A | <1% | 3,864 | $147K | |
| 59025 | Fetal non-stress test | <1% | 645 | $146K |
| 90677 | <1% | 3,755 | $143K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,062 | $140K |
| 59430 | <1% | 1,310 | $135K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 1,127 | $135K |
| 81002 | <1% | 62,606 | $135K | |
| 91320 | <1% | 2,244 | $133K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,562 | $133K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 8,082 | $129K |
| 99385 | <1% | 1,908 | $124K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 7,248 | $111K |
| D0140 | Limited oral evaluation - problem focused | <1% | 4,306 | $109K |
| 90837 | Psychotherapy session, about an hour | <1% | 2,980 | $107K |
| 0012A | <1% | 3,137 | $106K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 761 | $105K |
| 73610 | <1% | 4,645 | $102K | |
| 92558 | <1% | 706 | $98K | |
| D0330 | Panoramic radiographic image | <1% | 1,562 | $97K |
| 0071A | <1% | 2,178 | $96K | |
| 90714 | <1% | 3,881 | $94K | |
| 99397 | <1% | 1,368 | $94K | |
| D9110 | <1% | 3,107 | $93K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 15,507 | $93K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 7,757 | $92K |
| 73630 | <1% | 4,884 | $90K | |
| 90716 | <1% | 6,374 | $89K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 3,202 | $88K |
| 73562 | <1% | 5,998 | $88K | |
| 0072A | <1% | 1,932 | $87K | |
| 10060 | <1% | 477 | $86K | |
| 99205 | Prolong outpt/office vis | <1% | 826 | $84K |
| 90480 | <1% | 2,289 | $83K | |
| 97802 | <1% | 2,654 | $83K | |
| 0011A | <1% | 3,165 | $83K | |
| 90732 | <1% | 1,349 | $80K | |
| D0272 | Bitewings - two radiographic images | <1% | 3,194 | $78K |
| 74019 | <1% | 3,073 | $77K | |
| 73140 | <1% | 3,510 | $74K | |
| 73030 | <1% | 4,588 | $74K | |
| 99442 | <1% | 2,417 | $67K | |
| 92015 | Determination of refractive state | <1% | 5,463 | $67K |
| 0064A | <1% | 1,727 | $66K | |
| 92579 | <1% | 1,048 | $66K | |
| 90473 | <1% | 3,282 | $65K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 19,420 | $63K |
| 99201 | <1% | 919 | $63K | |
| 90671 | <1% | 2,054 | $62K | |
| 11983 | <1% | 533 | $62K | |
| 72100 | <1% | 3,596 | $60K | |
| 90670 | <1% | 12,802 | $58K | |
| 90658 | <1% | 2,578 | $57K | |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 813 | $55K |
| 73110 | <1% | 2,693 | $54K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 2,020 | $54K |
| 90707 | <1% | 6,481 | $52K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16,377 | $51K |
| 72040 | <1% | 1,738 | $51K | |
| 73130 | <1% | 2,812 | $48K | |
| 76536 | <1% | 844 | $47K | |
| 90696 | <1% | 3,507 | $46K | |
| 92567 | <1% | 2,525 | $46K | |
| 97803 | <1% | 1,186 | $46K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 581 | $42K |
| 92552 | <1% | 373 | $39K | |
| D0180 | <1% | 6,995 | $39K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 595 | $38K |
| D2331 | <1% | 1,278 | $37K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 1,292 | $37K |
| 87802 | <1% | 3,778 | $35K | |
| 20550 | <1% | 341 | $35K | |
| 17110 | <1% | 191 | $32K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,211 | $32K |
| 99386 | <1% | 511 | $31K | |
| 0031A | <1% | 1,040 | $30K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 3,324 | $30K |
| 72110 | <1% | 1,449 | $30K | |
| 36000 | <1% | 5,950 | $30K | |
| 0052A | <1% | 663 | $29K | |
| 90662 | <1% | 1,704 | $29K | |
| 73560 | <1% | 1,453 | $28K | |
| 0081A | <1% | 633 | $28K | |
| 92133 | <1% | 2,978 | $27K | |
| 69209 | <1% | 1,074 | $26K | |
| 99443 | <1% | 1,877 | $25K | |
| D4341 | <1% | 392 | $25K | |
| 73080 | <1% | 960 | $24K | |
| 92002 | <1% | 363 | $24K | |
| 99384 | <1% | 217 | $22K | |
| 90739 | <1% | 1,341 | $21K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 27,514 | $20K |
| 71101 | <1% | 933 | $20K | |
| 77080 | <1% | 318 | $19K | |
| 0051A | <1% | 446 | $19K | |
| 99441 | <1% | 2,187 | $19K | |
| 76801 | <1% | 249 | $19K | |
| 73502 | <1% | 884 | $18K | |
| D2740 | Crown - porcelain/ceramic | <1% | 528 | $17K |
| 0082A | <1% | 375 | $17K | |
| 90691 | <1% | 656 | $16K | |
| 93226 | <1% | 227 | $16K | |
| 12011 | <1% | 62 | $15K | |
| 93225 | <1% | 206 | $14K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 5,230 | $14K |
| 70470 | <1% | 130 | $14K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 322 | $13K |
| 90686 | <1% | 15,168 | $13K | |
| 99383 | <1% | 134 | $13K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 102 | $13K |
| 92555 | <1% | 939 | $12K | |
| 72070 | <1% | 525 | $12K | |
| 0154A | <1% | 363 | $12K | |
| 87210 | <1% | 3,408 | $12K | |
| D2751 | Crown - porcelain fused to predominantly base metal | <1% | 134 | $11K |
| D2140 | <1% | 248 | $11K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,915 | $11K |
| 76881 | <1% | 196 | $11K | |
| 90636 | <1% | 517 | $10K | |
| 90839 | <1% | 466 | $10K | |
| 72170 | <1% | 683 | $10K | |
| 82947 | <1% | 5,717 | $10K | |
| D5212 | <1% | 223 | $10K | |
| 73660 | <1% | 222 | $10K | |
| 96368 | <1% | 2,465 | $10K | |
| 87220 | <1% | 2,890 | $9K | |
| 59425 | <1% | 24 | $8K | |
| 69210 | <1% | 196 | $8K | |
| J3490 | Unclassified drugs | <1% | 739 | $8K |
| 87808 | <1% | 841 | $7K | |
| 96127 | <1% | 9,507 | $7K | |
| 92583 | <1% | 55 | $7K | |
| 94010 | <1% | 1,447 | $7K | |
| D2330 | <1% | 757 | $7K | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 1,021 | $7K |
| 12002 | <1% | 26 | $6K | |
| 72082 | <1% | 138 | $6K | |
| 85610 | <1% | 2,869 | $6K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 36 | $6K |
| 90632 | <1% | 268 | $6K | |
| 88720 | <1% | 1,298 | $5K | |
| D1354 | <1% | 363 | $5K | |
| 0003A | <1% | 131 | $5K | |
| 0074A | <1% | 236 | $5K | |
| 0083A | <1% | 102 | $5K | |
| 73565 | <1% | 306 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,058 | $5K |
| 0073A | <1% | 95 | $4K | |
| 76870 | <1% | 50 | $4K | |
| D4342 | <1% | 1,094 | $4K | |
| 92557 | <1% | 76 | $4K | |
| D2335 | <1% | 225 | $4K | |
| 90682 | <1% | 241 | $4K | |
| 20526 | <1% | 31 | $4K | |
| 73590 | <1% | 122 | $4K | |
| 92134 | <1% | 441 | $4K | |
| 92499 | <1% | 72 | $4K | |
| 73090 | <1% | 120 | $4K | |
| 73522 | <1% | 80 | $3K | |
| 90785 | <1% | 419 | $3K | |
| 91200 | <1% | 262 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 116 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,057 | $3K |
| 90474 | <1% | 2,325 | $3K | |
| 11900 | <1% | 39 | $3K | |
| D2332 | <1% | 160 | $2K | |
| 87536 | <1% | 340 | $2K | |
| 90633 | <1% | 8,980 | $2K | |
| 99188 | <1% | 1,888 | $2K | |
| 93224 | <1% | 399 | $2K | |
| 0124A | <1% | 43 | $2K | |
| 20605 | <1% | 12 | $2K | |
| 90734 | <1% | 4,870 | $2K | |
| 87905 | <1% | 208 | $2K | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 686 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 159 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,490 | $2K |
| D5211 | <1% | 33 | $2K | |
| 97810 | <1% | 44 | $2K | |
| 74018 | <1% | 88 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 144 | $2K |
| 96367 | <1% | 130 | $2K | |
| 87807 | <1% | 140 | $2K | |
| 92083 | <1% | 468 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 98 | $1K |
| D2950 | <1% | 149 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 84 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 5,003 | $1K |
| 92250 | <1% | 266 | $1K | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 831 | $1K |
| 77072 | <1% | 25 | $1K | |
| 90713 | <1% | 120 | $989.93 | |
| D0270 | <1% | 224 | $968.00 | |
| 0013A | <1% | 21 | $963.27 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 113 | $826.63 |
| 91308 | <1% | 1,117 | $825.60 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 225 | $786.55 |
| 0173A | <1% | 18 | $779.79 | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 45 | $756.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 18 | $668.56 |
| 92556 | <1% | 27 | $652.82 | |
| 92310 | <1% | 13 | $648.84 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 412 | $619.20 |
| 90679 | <1% | 43 | $618.04 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 27 | $559.00 |
| 29125 | <1% | 55 | $547.47 | |
| 94150 | <1% | 41 | $512.52 | |
| 72220 | <1% | 13 | $476.64 | |
| 0053A | <1% | 15 | $458.70 | |
| 90710 | <1% | 2,958 | $458.49 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 13 | $436.70 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,496 | $417.73 |
| 90743 | <1% | 1,015 | $262.50 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 293 | $243.67 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 12 | $212.28 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 114 | $190.45 |
| 82272 | <1% | 72 | $188.53 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 70 | $160.97 |
| 97811 | <1% | 28 | $157.04 | |
| 90656 | <1% | 151 | $149.55 | |
| 94761 | <1% | 3,239 | $143.66 | |
| 90649 | <1% | 12 | $137.59 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 299 | $136.92 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 974 | $122.34 |
| 82565 | <1% | 340 | $113.00 | |
| 82274 | <1% | 19 | $70.00 | |
| J1815 | Injection, insulin, per 5 units | <1% | 83 | $54.53 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 604 | $20.35 |
| 94760 | <1% | 2,747 | $19.80 | |
| 96160 | <1% | 2,010 | $6.41 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 99 | $1.57 |
| 90700 | 0% | 3,226 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 2,699 | $0.00 |
| 90648 | 0% | 6,697 | $0.00 | |
| 91300 | 0% | 38,065 | $0.00 | |
| 90681 | 0% | 5,064 | $0.00 | |
| 92582 | 0% | 26 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 154 | $0.00 |
| 91312 | 0% | 5,544 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 29 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 687 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 51 | $0.00 |
| 90611 | 0% | 267 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 100 | $0.00 |
| 99177 | 0% | 5,561 | $0.00 | |
| 90687 | 0% | 59 | $0.00 | |
| J7645 | Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | 0% | 44 | $0.00 |
| 90685 | 0% | 487 | $0.00 | |
| 90661 | 0% | 1,489 | $0.00 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 0% | 174 | $0.00 |
| 90380 | 0% | 43 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 18 | $0.00 |
| 91313 | 0% | 147 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 16 | $0.00 |
| J1055 | 0% | 13 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 3,234 | $0.00 |
| 91301 | 0% | 6,398 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 638 | $0.00 |
| 96161 | 0% | 5,648 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 2,226 | $0.00 |
| 91305 | 0% | 4,911 | $0.00 | |
| 91306 | 0% | 1,733 | $0.00 | |
| 90723 | 0% | 3,477 | $0.00 | |
| 90744 | 0% | 3,320 | $0.00 | |
| D0603 | 0% | 979 | $0.00 | |
| D5000 | 0% | 1,291 | $0.00 | |
| V5008 | Hearing screening | 0% | 2,472 | $0.00 |
| 99417 | Prolong home eval add 15m | 0% | 331 | $0.00 |
| 90680 | 0% | 3,089 | $0.00 | |
| D0602 | 0% | 291 | $0.00 | |
| D0601 | 0% | 397 | $0.00 | |
| 91315 | 0% | 364 | $0.00 | |
| 91307 | 0% | 4,440 | $0.00 | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 0% | 15 | $0.00 |
| 90698 | 0% | 6,493 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 336 | $0.00 |
| 91317 | 0% | 19 | $0.00 | |
| 90697 | 0% | 557 | $0.00 | |
| 90657 | 0% | 26 | $0.00 | |
| 91303 | 0% | 1,042 | $0.00 | |
| D1330 | 0% | 43 | $0.00 | |
| 90619 | 0% | 805 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 139 | $0.00 |
| 99024 | 0% | 42 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 44 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 14 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 34 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTAYLOR, JAMES (CHIEF MEDICAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Acea Home Health LLC. | Henderson, TX | $3.02M |
| Weston Lewis County Emergency Ambulance Service Authority | Weston, WV | $2.40M |
| Taylored Rehab, LLC | Fond Du Lac, WI | $60K |
| Treesap Clinic, INC. | Walnut, MS | $59K |
| Jim G. Taylor, O.D.P.C. | Paris, TN | $45K |
| Taylor Family Chiropractic Office, PLLC | Middlesboro, KY | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.